DAVID
BALGOMA HERNANDO
INVESTIGADOR POSDOCTORAL MARIA ZAMBRANO
Karolinska University Hospital
Estocolmo, SueciaPublikationen in Zusammenarbeit mit Forschern von Karolinska University Hospital (9)
2022
-
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
European Respiratory Journal, Vol. 59, Núm. 2
2021
-
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation
American Journal of Respiratory and Critical Care Medicine, Vol. 203, Núm. 1, pp. 37-53
2019
-
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
European Respiratory Journal
2018
-
A computational framework for complex disease stratification from multiple large-scale datasets
BMC Systems Biology, Vol. 12, Núm. 1
2016
-
Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD
European Respiratory Journal, Vol. 47, Núm. 6, pp. 1645-1656
2015
-
The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma
Chest, Vol. 147, Núm. 2, pp. 397-405
2014
-
Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma
Journal of Allergy and Clinical Immunology, Vol. 134, Núm. 2, pp. 306-313
2013
-
Quantification of lipid mediator metabolites in human urine from asthma patients by electrospray ionization mass spectrometry: Controlling matrix effects
Analytical Chemistry, Vol. 85, Núm. 16, pp. 7866-7874
2011
-
Lipid mediators in severe asthma
DIFFICULT-TO-TREAT SEVERE ASTHMA (EUROPEAN RESPIRATORY SOCIETY), pp. 218-235